|
ABOUT COMPANY
Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California.
|
EARNINGS
Gross Profit (TTM): 50763000
Market Capitalization: 1173131000
Operating Margin (TTM): -0.47
PE Ratio: None
PEG Ratio: 0
Profit Margin: -0.5
Revenue Per Share (TTM): 0.702
Revenue (TTM): 119193000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0.531
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.356
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -59358000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|